August Zabernigg

2.6k total citations
57 papers, 1.6k citations indexed

About

August Zabernigg is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, August Zabernigg has authored 57 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 7 papers in Pathology and Forensic Medicine. Recurrent topics in August Zabernigg's work include Cancer survivorship and care (11 papers), Gastric Cancer Management and Outcomes (7 papers) and Lung Cancer Treatments and Mutations (7 papers). August Zabernigg is often cited by papers focused on Cancer survivorship and care (11 papers), Gastric Cancer Management and Outcomes (7 papers) and Lung Cancer Treatments and Mutations (7 papers). August Zabernigg collaborates with scholars based in Austria, United States and Switzerland. August Zabernigg's co-authors include Bernhard Holzner, Johannes M. Giesinger, Eva‐Maria Gamper, Georg Kemmler, Anne Oberguggenberger, Lisa M. Wintner, Gerhard Rumpold, Barbara Sperner‐Unterweger, K. Gattringer and Wolfgang Hilbe and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

August Zabernigg

57 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
August Zabernigg Austria 22 684 401 224 211 185 57 1.6k
Risa Shorr Canada 23 552 0.8× 358 0.9× 31 0.1× 140 0.7× 55 0.3× 136 1.9k
Douglas Farquhar United States 18 182 0.3× 168 0.4× 88 0.4× 72 0.3× 78 0.4× 65 917
Thomas E. Lad United States 22 1.1k 1.6× 618 1.5× 20 0.1× 194 0.9× 45 0.2× 74 1.9k
Tal Schechter Canada 20 282 0.4× 135 0.3× 23 0.1× 377 1.8× 37 0.2× 122 1.4k
Tomas L. Griebling United States 27 115 0.2× 348 0.9× 52 0.2× 98 0.5× 22 0.1× 107 2.5k
A. Prins Netherlands 21 207 0.3× 124 0.3× 25 0.1× 107 0.5× 31 0.2× 25 1.2k
John Wiernikowski Canada 15 318 0.5× 136 0.3× 92 0.4× 163 0.8× 15 0.1× 28 814
Charles Weissman Israel 21 251 0.4× 286 0.7× 11 0.0× 186 0.9× 43 0.2× 80 1.5k
Lawrence Berk United States 24 625 0.9× 534 1.3× 10 0.0× 103 0.5× 31 0.2× 56 2.0k
Irene R. Dégano Spain 26 86 0.1× 90 0.2× 28 0.1× 183 0.9× 38 0.2× 83 2.0k

Countries citing papers authored by August Zabernigg

Since Specialization
Citations

This map shows the geographic impact of August Zabernigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by August Zabernigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites August Zabernigg more than expected).

Fields of papers citing papers by August Zabernigg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by August Zabernigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by August Zabernigg. The network helps show where August Zabernigg may publish in the future.

Co-authorship network of co-authors of August Zabernigg

This figure shows the co-authorship network connecting the top 25 collaborators of August Zabernigg. A scholar is included among the top collaborators of August Zabernigg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with August Zabernigg. August Zabernigg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rössler, Annika, Janine Kimpel, Silke Huber, et al.. (2022). Regimen of Coronavirus Disease 2019 Vaccination Influences Extent and Kinetics of Antibody Avidity. The Journal of Infectious Diseases. 226(11). 1909–1912. 1 indexed citations
3.
Lee, Hye‐Kyung, Ludwig Knabl, Mary Walter, et al.. (2022). Prior Vaccination Exceeds Prior Infection in Eliciting Innate and Humoral Immune Responses in Omicron Infected Outpatients. Frontiers in Immunology. 13. 916686–916686. 20 indexed citations
4.
Knabl, Ludwig, Hye‐Kyung Lee, August Zabernigg, et al.. (2022). BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant. SHILAP Revista de lepidopterología. 2(1). 20 indexed citations
5.
Fridrik, Michael, Andreas Leiherer, August Zabernigg, et al.. (2017). A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients. Supportive Care in Cancer. 26(4). 1345–1352. 8 indexed citations
6.
7.
Holzner, Bernhard, et al.. (2015). Patients’ Preferences Regarding The Setting Of Electronic Patient-Reported Outcome Assessments. Value in Health. 18(7). A473–A473. 3 indexed citations
8.
Kuijpers, Wilma, Johannes M. Giesinger, August Zabernigg, et al.. (2015). Patients’ and health professionals’ understanding of and preferences for graphical presentation styles for individual-level EORTC QLQ-C30 scores. Quality of Life Research. 25(3). 595–604. 34 indexed citations
9.
Fiegl, Michael, Andreas Pircher, Gabriele Gamerith, et al.. (2014). Small steps of improvement in small-cell lung cancer (SCLC) within two decades: A comprehensive analysis of 484 patients. Lung Cancer. 84(2). 168–174. 23 indexed citations
10.
Fiegl, Michael, Reinhard Stauder, Michael Steurer, et al.. (2013). Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients. Annals of Hematology. 93(2). 267–277. 12 indexed citations
11.
Beauchamp, Jonathan, Jens Herbig, Jürgen Dunkl, et al.. (2013). First observation of a potential non-invasive breath gas biomarker for kidney function. Journal of Breath Research. 7(1). 17110–17110. 31 indexed citations
12.
Zabernigg, August, Johannes M. Giesinger, Georg Pall, et al.. (2012). Quality of life across chemotherapy lines in patients with cancers of the pancreas and biliary tract. BMC Cancer. 12(1). 390–390. 32 indexed citations
13.
Giesinger, Johannes M., Lisa M. Wintner, Anne Oberguggenberger, et al.. (2011). Quality of Life Trajectory in Patients with Advanced Cancer during the Last Year of Life. Journal of Palliative Medicine. 14(8). 904–912. 65 indexed citations
14.
Fiegl, Michael, Martin Erdel, Ingeborg Tinhofer, et al.. (2010). Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories. Annals of Oncology. 21(12). 2410–2419. 22 indexed citations
15.
Giesinger, Johannes M., Georg Kemmler, August Zabernigg, et al.. (2009). Are gender-associated differences in quality of life in colorectal cancer patients disease-specific?. Quality of Life Research. 18(5). 547–555. 24 indexed citations
16.
Petru, Edgar, Johannes Andel, Günther Steger, et al.. (2008). Early Austrian multicenter experience with palonosetron as antiemetic treatment for patients undergoing highly or moderately emetogenic chemotherapy. Wiener Medizinische Wochenschrift. 158(5-6). 169–173. 6 indexed citations
17.
Fiegl, Michael, Georg Hopfinger, Stefan Brugger, et al.. (2006). Routine clinical use of alemtuzumab in patients with heavily pretreated B‐cell chronic lymphocytic leukemia. Cancer. 107(10). 2408–2416. 29 indexed citations
18.
Schmidinger, Manuela, Alexandra C. Budinsky, Catharina Wenzel, et al.. (2000). Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial. Cancer Chemotherapy and Pharmacology. 47(1). 57–62. 7 indexed citations
19.
Jaschke, E, August Zabernigg, & Claus Gattringer. (1999). Recombinant human granulocyte‐macrophage colony‐stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers. International Journal of Dermatology. 38(5). 380–386. 72 indexed citations
20.
Zabernigg, August, Falko Fend, Josef Thaler, & Claus Gattringer. (1996). An Unusual Case of a Splenic Gamma/Delta T-cell Lymphoma with Angiocentric Tendency and Haemophagocytic Syndrome. Leukemia & lymphoma. 23(5-6). 631–634. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Risa Shorr Breakdown of academic impact, for papers by Douglas Farquhar Breakdown of academic impact, for papers by Thomas E. Lad Breakdown of academic impact, for papers by Tal Schechter Breakdown of academic impact, for papers by Tomas L. Griebling Breakdown of academic impact, for papers by A. Prins Breakdown of academic impact, for papers by John Wiernikowski Breakdown of academic impact, for papers by Charles Weissman Breakdown of academic impact, for papers by Lawrence Berk Breakdown of academic impact, for papers by Irene R. Dégano
Rankless by CCL
2026